EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of a Krill Oil, Astaxanthin, and Oral Hyaluronic Acid Complex on Joint Health in People with Mild Osteoarthritis

W Stephen Hill, Margaret H Dohnalek, Yejin Ha, Seok-Jung Kim iD, Jae-Chul Jung, Seung-Baik Kang

Nutrients · 2023

DOI: 10.3390/nu15173769 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2023. Verfasst von W Stephen Hill und 5 weiteren Autor:innen. Beteiligte Einrichtung: US Nutraceuticals, Inc. d/b/a Valensa International, Eustis, FL 32726, USA. Hauptthemen laut MEDLINE: Euphausiacea, Osteoarthritis. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Trade, Industry and Energy, World Class Plus Program, NOVAREX Co., Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis is a significant global health problem. Many patients seek more effective alternatives to nonsteroidal anti-inflammatory medicines or commercial supplements to manage joint pain and inflammation. FlexPro MD® (FP-MD) combines krill oil, astaxanthin, and lower molecular weight hyaluronic acid to support joint health. A 12-week, randomized, double-blind, placebo-controlled trial compared the efficacy and safety of FP-MD and placebo once daily in participants (n = 100) with mild osteoarthritis of the knee or hip joint. For the primary endpoint of joint pain score, per-protocol participants (n = 75) in the FP-MD group (n = 37) had a statistically significantly greater mean reduction from baseline in the Korean Visual Analog Scale (K-VAS) at week 12 compared with participants in the placebo group (n = 38) (20.8 ± 16.16 mm vs. 10.6 ± 17.58, p = 0.0105). The Korean Western Ontario and McMaster Universities Osteoarthritis Index (K-WOMAC) total score was also significantly improved in the FP-MD group at week 12 compared with placebo (−13.0 ± 13.62 vs. −5.5 ± 18.08, p = 0.0489), especially an improvement in pain score (−2.5 ± 2.92 vs. −1.3 ± 3.94, p = 0.02635). FP-MD group had greater improvement in joint function scoring by investigator assessment (p = 0.0127) and by group participants (p = 0.0070). A statistically significantly greater number of patients reported adverse events in the placebo group compared with the FP-MD group (16% vs. 4%, p = 0.0455), most commonly gastrointestinal disorders in both of the groups. These findings suggest that FP-MD is well tolerated and can be effectively used to address joint pain in patients diagnosed with mild osteoarthritis, the main symptom of this condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EuphausiaceaOsteoarthritisHumansAnimalsHyaluronic AcidArthralgiaXanthophylls

Stichwörter der Autor:innen

FlexPro MD®astaxanthinhyaluronic acidinflammationjoint painkrill oilosteoarthritis

Substanzen

Hyaluronic AcidastaxanthineXanthophylls

Autor:innen und Institutionen

  • US Nutraceuticals, Inc. d/b/a Valensa International, Eustis, FL 32726, USA.
  • NOVAREX Co., Ltd., 80, Osongsaengmyeong 14-ro, Osong-eup, Chueongju-si 28220, Republic of Korea.
  • Department of Orthopedic Surgery, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Cheonbo-ro, Uijeongbu-si 11765, Republic of Korea.
  • Department of Orthopedic Surgery, Seoul National University College of Medicine, Boramae Hospital, Seoul 07061, Republic of Korea.

ORCID-Profile: Seok-Jung Kim

Förderung

  • Ministry of Trade, Industry and Energy
  • World Class Plus Program
  • NOVAREX Co., Ltd.
  • Valensa International

Zitieren

APA

Hill, W. S., Dohnalek, M. H., Ha, Y., Kim, S. J., Jung, J. C., & Kang, S. B. (2023). A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of a Krill Oil, Astaxanthin, and Oral Hyaluronic Acid Complex on Joint Health in People with Mild Osteoarthritis. Nutrients. https://doi.org/10.3390/nu15173769

Vancouver

Hill WS, Dohnalek MH, Ha Y, Kim SJ, Jung JC, Kang SB. A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of a Krill Oil, Astaxanthin, and Oral Hyaluronic Acid Complex on Joint Health in People with Mild Osteoarthritis. Nutrients. 2023. doi:10.3390/nu15173769

BibTeX
@article{Hill2023,
  author = {Hill, W Stephen and Dohnalek, Margaret H and Ha, Yejin and Kim, Seok-Jung and Jung, Jae-Chul and Kang, Seung-Baik},
  title = {A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of a Krill Oil, Astaxanthin, and Oral Hyaluronic Acid Complex on Joint Health in People with Mild Osteoarthritis},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15173769}
}
Kostenlos starten →